NP137 Clinical and Biological Activities Assessment in Patients With Advanced/Metastatic Solid Tumors Treated by Standard Anti PD-1/PD-L1 Immunotherapies
NP137 Clinical and Biological Activities Assessment in Patients With Advanced/Metastatic Solid Tumors Treated by Standard Anti PD-1/PD-L1 Immunotherapies
Active, not recruiting · NCT05605496 · Registry updated 2026-09-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| NP137 Clinical and Biological Activities Assessment in Patients With Advanced/Metastatic Solid Tumors Treated by Standard Anti PD-1/PD-L1 Immunotherapies | Advanced Solid Tumors; Metastatic Solid Tumors | Active, not recruiting | Phase 2 | 2026-09-25 | NCT05605496 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Centre Leon Berard | 67 |
| NETRIS Pharma | 4 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centre Antoine Lacassagne | Nice | France | 83 |
| Centre Léon Bérard | Lyon | France | 50 |
| Institut Claudius Regaud (IUCT Oncopole) | Toulouse | France | 1 |
| Institut Curie | Paris | France | 81 |
| Institut de cancérologie Strasbourg Europe (ICANS) | Strasbourg | France | 4 |